Photo Source: Egyptian Drug Authority The Ministry of Health launched the country’s first locally produced long-acting insulin on 17 December, through a partnership between Egyptian pharmaceutical company Eva Pharma and global giant Eli Lilly and Company. Health Minister Khaled Abdel-Ghaffar underscored the significance of the moment. “Egypt is prioritizing the localization of pharmaceutical production,” he stated at the launch event at Eva Pharma’s factory in Giza. “Our new collaboration with EVA Pharma reflects Lilly’s deep commitment to making equitable and affordable access to insulin a reality for people living with diabetes in low- and middle-income countries,” also said Ilya Yuffa, president of Lilly International. “This latest initiative from Lilly will empower local manufacturing, finishing, and distribution of quality insulin – in Africa – which will transform communities and make life better for people throughout the continent.” A Collaborative Effort for Affordable Treatment The journey to locally produced insulin began in 2022, when Eva Pharma and Eli Lilly forged a collaboration focused on delivering affordable medication to low- and middle-income countries. Eli Lilly provides the active ingredient and shares technology pro bono, enabling Eva Pharma to manufacture and package insulin locally.Continue reading "Egypt Takes a Leap Toward Health Independence with Locally Produced Insulin"
Egypt Takes a Leap Toward Health Independence with Locally Produced Insulin first appeared on Egyptian Streets.
Read More Details
Finally We wish PressBee provided you with enough information of ( Egypt Takes a Leap Toward Health Independence with Locally Produced Insulin )
Also on site :
- Child Damages $56 Million Rothko Painting in Rotterdam Museum
- Four dead after car crashes into after-school camp in US state of Illinois
- Videos capture fighting during Israeli raid in occupied West Bank